IL-15 mediated expansion of rare durable memory T cells following adoptive cellular therapy

BACKGROUND: Synovial sarcoma (SS) and myxoid/round cell liposarcoma (MRCL) are ideal solid tumors for the development of adoptive cellular therapy (ACT) targeting NY-ESO-1, as a high frequency of tumors homogeneously express this cancer-testes antigen. Data from early phase clinical trials have show...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:J Immunother Cancer
Κύριοι συγγραφείς: Kohli, Karan, Yao, Lu, Nowicki, Theodore Scott, Zhang, Shihong, Black, Ralph Graeme, Schroeder, Brett A, Farrar, Erik A, Cao, Jianhong, Sloan, Heather, Stief, Dawn, Cranmer, Lee D, Wagner, Michael J, Hawkins, Douglas S, Pillarisetty, Venu G, Ribas, Antoni, Campbell, Jean, Pierce, Robert H, Kim, Edward Y, Jones, Robin L, Riddell, Stanley R, Yee, Cassian, Pollack, Seth M
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: BMJ Publishing Group 2021
Θέματα:
Immune Cell Therapies and Immune Cell Engineering
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8108691/
https://ncbi.nlm.nih.gov/pubmed/33963013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-002232
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια